Sheaff Brock Investment Advisors »

Catalyst Pharmaceutical Partners shares owned by Sheaff Brock Investment Advisors

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Sheaff Brock Investment Advisors from 13F filings

Historical chart of Sheaff Brock Investment Advisors investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Sheaff Brock Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Sheaff Brock Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-03-31 $495k 20k 24.25
2023-03-31 $175k 11k 16.58

More positions owned by Sheaff Brock Investment Advisors

Apple (AAPL)
Nvidia Corporation Put Put Option (Principal) (NVDA)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Listed Fd Tr Dividend Perfmrs
International Business Machines (IBM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Oracle Corporation (ORCL)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Abbvie (ABBV)
Broadcom (AVGO)
Kla Corp Com New (KLAC)
Qualcomm (QCOM)

View all positions for Sheaff Brock Investment Advisors

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management
Northern Trust

View all funds holding Catalyst Pharmaceutical Partners